Indicated for: chronic obstructive pulmonary disease
Route of administration: inhalation
Substance: olodaterol (beta-2 adrenergic agonist)
ATC: R03AC19 (Respiratory system | Adrenergics, inhalants | Selective beta-2-adrenoreceptor agonists)
Olodaterol is a long-acting beta-2 adrenergic agonist used for the treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It works by relaxing the smooth muscles of the airways, making breathing easier.
The medication is administered via an inhaler, usually once daily, as directed by a doctor. It is important for patients to use the medication regularly to achieve maximum benefits.
Patients should be aware of potential side effects, such as tremors, palpitations, or headaches. It is important to inform the doctor of any unusual symptoms.
Common side effects include tremors, palpitations, headaches, and dry mouth. In rare cases, severe reactions such as paradoxical bronchospasm or allergic reactions may occur. Patients should be informed of these risks before starting treatment.